Mandating HPV vaccination: what are the arguments?
Smith
Christy M
CM
Indiana Wesleyan University, USA.
D000293:Adolescent; D000328:Adult; D052685:Alphapapillomavirus; D034462:Dissent and Disputes; D016527:Drug Costs; D005260:Female; D006287:Health Planning Guidelines; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D017589:Immunization Programs / Q000458:organization & administration*; D037141:Mandatory Programs / Q000458:organization & administration*; D024802:Nurse's Role; D030361:Papillomavirus Infections / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000191:economics; D033282:Parental Consent; D010353:Patient Education as Topic; D012449:Safety; D012725:Sexual Behavior; D014481:United States / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control / Q000821:virology
D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines